Comprehensive Clinical Assessment
Your care begins with a detailed review of your diagnosis, previous treatments, medical history, and overall health to determine whether CAR-T Cell Therapy is suitable for you.
Cancer Treatments
Understanding CAR-T Cell Therapy
Cancer treatment continues to evolve, creating new possibilities for patients who may benefit from highly specialised therapies. CAR-T Cell Therapy is one of the most significant advances in modern cancer care, using a patient's own immune cells to recognise and fight certain types of cancer.
The treatment begins by collecting specialised immune cells called T-cells from your blood. These cells are then modified in a specialised laboratory to better recognise cancer cells before being returned to your body, where they continue to identify and attack cancer more effectively.
Because cancer CAR-T cell therapy is a highly specialised treatment, it is recommended only after a detailed clinical evaluation. At IOHC, every recommendation is guided by your diagnosis, previous treatments, overall health, and the latest clinical evidence to determine whether this advanced therapy is appropriate for your care.
When Is CAR-T Cell Therapy Recommended?
CAR-T Cell Therapy is currently recommended for selected blood cancers and is considered only for patients who meet specific clinical criteria. The decision is based on the type of cancer, previous treatments, overall health, and a detailed assessment by your oncology team.
Your specialist may recommend CAR-T Cell Therapy if:
- You have certain types of leukaemia or lymphoma that may benefit from CAR-T therapy.
- Previous cancer treatments have not achieved the desired response.
- A comprehensive evaluation confirms you are clinically eligible.
- Advanced cellular therapy is considered an appropriate treatment option.
- Your care team believes CAR-T Cell Therapy offers the most suitable next step in your treatment plan.
Planning a Highly Specialised Treatment
CAR-T Cell Therapy involves several carefully coordinated stages, each designed to ensure the treatment is safe, appropriate, and personalised to your needs.
Confirming Your Eligibility
Not every patient is eligible for CAR-T therapy. Additional investigations and specialist assessments help determine whether this treatment is likely to provide clinical benefit.
Preparing Your Treatment
If CAR-T Cell Therapy is recommended, your T-cells are collected and sent to a specialised laboratory, where they are modified before being returned for treatment. Every step follows carefully monitored clinical protocols.
Close Monitoring Throughout Care
Following treatment, regular monitoring helps your care team assess your response, identify any side effects early, and provide timely medical support whenever required.
Continuing Care Beyond Treatment
Recovery continues after the infusion. Scheduled follow-up visits, ongoing assessments, and supportive care help monitor your progress and guide the next stage of your care.
Preparing for CAR-T Cell Therapy
CAR-T Cell Therapy requires careful preparation before treatment begins. Your oncology team will explain each stage of the process, answer your questions, and guide you through the investigations and appointments required before therapy.
Do's
- Attend all recommended consultations and pre-treatment assessments.
- Keep your medical records and previous treatment history organised.
- Inform your care team about any new symptoms or existing medical conditions.
- Follow all instructions before and after your treatment.
- Stay connected with your oncology team throughout the treatment process.
Don'ts
- Do not miss scheduled investigations or follow-up appointments.
- Avoid starting new medicines without discussing them with your doctor.
- Do not ignore symptoms after treatment, even if they appear mild.
- Avoid relying on incomplete online information instead of specialist advice.
- Do not hesitate to ask questions at any stage of your care.
Care That Continues Beyond Treatment
CAR-T Cell Therapy does not end with the infusion. Careful monitoring and follow-up remain an important part of the treatment process to understand how your body is responding and to support your recovery.
At IOHC, patients receiving CAR-T Cell Therapy are supported through regular clinical reviews, coordinated follow-up care, symptom management, and multidisciplinary expertise. Every stage of care is focused on helping you recover safely while ensuring your treatment continues to be guided by your individual needs.
Request AppointmentFrequently Asked Questions
Questions About CAR-T Cell Therapy
CAR-T Cell Therapy is an advanced form of cancer CAR-T Cell Therapy that uses a patient's own T-cells to recognise and attack certain cancer cells. These immune cells are collected, modified in a specialised laboratory, and then returned to the body to help fight cancer more effectively.
The treatment involves:
- Collecting your T-cells.
- Modifying them in a specialised laboratory.
- Reinfusing the cells to target cancer.
CAR-T Cell Therapy is recommended for selected patients with specific blood cancers after a detailed clinical assessment. The decision to offer CAR-T Cell Therapy treatment depends on the type of cancer, previous treatments, and your overall health.
Eligibility is based on:
- Your diagnosis.
- Previous treatment response.
- Comprehensive specialist evaluation.
At present, CAR-T Cell Therapy is primarily used to treat selected blood cancers, including certain types of leukaemia and lymphoma. CAR-T Cell Therapy for leukaemia has shown encouraging outcomes in appropriately selected patients, while its use for other cancers continues to evolve.
It may be considered for:
- Certain types of leukaemia.
- Selected lymphomas.
- Other approved indications based on clinical guidance.
Yes. CAR-T Cell Therapy in India is available at specialised oncology centres for patients who meet the recommended clinical criteria. Your oncology team will determine whether CAR-T Cell Therapy treatment in India is suitable for your diagnosis after a detailed evaluation.
Your assessment may include:
- Clinical consultation.
- Diagnostic investigations.
- Eligibility review by a multidisciplinary team.
Yes. Patients seeking CAR-T Cell Therapy in Mumbai should first undergo a comprehensive evaluation to determine whether this treatment is appropriate for their condition. Recommendations are always based on clinical suitability rather than diagnosis alone.
The process includes:
- Detailed medical assessment.
- Review of previous treatments.
- Personalised treatment planning.
Research into CAR-T Cell Therapy for solid tumors is continuing, and its role is still evolving. While CAR-T therapy is currently established for certain blood cancers, its use for solid tumours remains an active area of clinical research and may not be suitable for every patient.
Treatment decisions depend on:
- The type of cancer.
- Current clinical evidence.
- Individual eligibility criteria.
Like all advanced cancer treatments, CAR-T Cell Therapy may cause side effects that require careful monitoring. Patients receiving cancer CAR-T Cell Therapy are closely observed by their oncology team so that any side effects can be identified and managed promptly.
Monitoring helps manage:
- Early treatment-related reactions.
- Changes in your overall health.
- Recovery following treatment.
Related Cancer Treatments
Visit IOHC — Mumbai
1101, 11th Floor, Shrikant Chamber-2 Next to R.K Studio, Union Park, Chembur Mumbai, Maharashtra 400071
Get Directions